Antimonene Nanosheets-Based Z-Scheme Heterostructure with Enhanced Reactive Oxygen Species Generation and Photothermal Conversion Efficiency for Photonic Therapy of Cancer

Adv Healthc Mater. 2021 Feb;10(3):e2001835. doi: 10.1002/adhm.202001835. Epub 2020 Nov 16.

Abstract

A Z-scheme heterojunction with high separation efficiency of photogenerated electrons and holes and enhanced reduction/oxidation potentials, which can enhance reactive oxygen species generation and photothermal conversion efficiency, exhibits tremendous potential in photonic theranostics. Herein, antimonene nanosheets (Sb NSs) are functionalized with photosensitizer 5,10,15,20-Tetrakis(4-hydroxy-phenyl)-21H,12H-porphine (THPP) and a poly(ethylene glycol) (PEG) modifier. The Sb-THPP-PEG NSs thus fabricated are found to form a Z-scheme heterojunction structure between Sb and THPP, based on their valence band and bandgap level analysis. The Z-scheme heterojunction structure enables the Sb-THPP-PEG NSs multiple promising features for cancer therapy. Firstly, due to improved electron-hole pairs separation efficiency and redox potential, new reactive oxygen species •O2- is generated, besides the production of 1 O2 by THPP. Secondly, the assembly of THPP enhances the NIR-light-to-heat conversion of Sb NS, a photothermal conversion efficiency as high as 44.6% is obtained by this Sb-THPP-PEG NSs photonic nanomedicine. Moreover, the photothermal, fluorescent, and photoacoustic imaging properties of Sb-THPP-PEG NSs allow multimodal imaging-guided tumor treatment.

Keywords: Z-scheme heterojunction; antimonene; nanomedicine; photodynamic therapy; photothermal therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Nanomedicine
  • Neoplasms* / drug therapy
  • Photochemotherapy*
  • Photosensitizing Agents / therapeutic use
  • Reactive Oxygen Species

Substances

  • Photosensitizing Agents
  • Reactive Oxygen Species